Podocalyxin-like 1 (PODXL) is a transmembrane glycoprotein belonging to the CD34 family of sialomucins, primarily known for its expression in renal podocytes and vascular endothelial cells. In addition to its localization in the kidney, PODXL is also found in various other tissues, including hematopoietic progenitor cells, vascular endothelium, and some epithelial cells. Functionally, PODXL plays crucial roles in cell adhesion, migration, and signal transduction, thereby contributing to various physiological and pathological processes. It interacts with numerous extracellular matrix proteins, such as podocalyxin-binding protein (PCBP), ezrin-radixin-moesin (ERM) proteins, and CD44, to regulate cell-cell and cell-matrix interactions. Furthermore, PODXL is involved in the modulation of intracellular signaling pathways, including those mediated by Rho GTPases, Src family kinases, and the phosphoinositide 3-kinase (PI3K)/Akt pathway, which regulate cytoskeletal dynamics, cell motility, and survival.
Activation of PODXL can occur through several mechanisms, primarily involving post-translational modifications and signaling cascades initiated by extracellular cues. Phosphorylation of specific tyrosine and serine residues within the cytoplasmic domain of PODXL by receptor tyrosine kinases (RTKs) or non-receptor kinases, such as Src family kinases, can enhance its adhesive properties and downstream signaling activity. Additionally, cleavage of the extracellular domain of PODXL by proteases, such as ADAM10 and MMPs, can release soluble fragments capable of modulating cell-cell interactions and signaling events. Furthermore, engagement of PODXL with its ligands, such as PCBP and CD44, can induce conformational changes that potentiate its adhesive and signaling functions. Collectively, these activation mechanisms contribute to the regulation of cellular processes associated with PODXL, including cell adhesion, migration, and survival, and underscore its importance in both normal physiology and disease pathogenesis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Demethylates genes, potentially increasing PODXL expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Affects retinoic acid receptors, possibly upregulating PODXL. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Rho-associated kinase (ROCK) inhibitor, which can influence PODXL localization. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Calcium ionophore that can modulate calcium-sensitive pathways affecting PODXL. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
CaMKII inhibitor, affecting pathways that may regulate PODXL expression. | ||||||